Strains, plasmids, and medium. Tables 2, 3, or S1 represent a list of the strains, plasmids, or primers used in this study, respectively. The yeast S. cerevisiae laboratory strain X2180-1A (MATa SUC2 mal mel gal2 CUP1) was a host strain to construct the yeast strains used in this study52. To generate the strain expressing Pdc1 fused with myc7His-tag at its C-terminus (Pdc1-myc7His) from the genome (the PDC1-myc7His strain), the DNA fragment amplified using the primers listed in Table S1 and plasmid pYM46 (Euroscarf) as a template was introduced into strain X2180-1A by the LiAc method53,54. For the construction of strain lacking both the PDC1 and URA3 genes (pdc1Δ ura3Δ), the DNA fragment amplified using primers listed in Table S1 and the plasmid pYM20 as a template was introduced to the strain lacking the URA3 gene constructed in the previous study55. In order to construct the strain lacking the ARG1 and LYS1 genes (arg1∆ lys1∆), which is capable to synthesize neither arginine (Arg) nor lysine (Lys), for the SILAC-based proteomic analysis, strain X2180-1A was transformed with the DNA fragment amplified from plasmid pFA6a-natNT2 (Euroscarf), followed by the further transformation with the fragment from plasmid pFA6a-hphNT1 (Euroscarf), using the primers shown in Table S1. Each positive clone was screened on the solid medium containing antibiotics G418 or hygromycin B. E. coli DH5α or BL21 (DE3) strain was used to construct plasmids or express Pdc1, respectively.
Table 2
Yeast strains used in this study
Strains | Genotype |
X2180-1A | MATa SUC2 mal mel gal2 CUP1 |
PDC1-myc7His | X2180-1A PDC1::PDC1-myc7His-kanMX6 |
arg1∆ lys1∆ | X2180-1A arg1∆::natNT2 lys1∆::hphNT1 |
WT-PDC1 | X2180-1A ura3∆::kanMX4 pdc1∆::hph pRS416::PDC1-myc7His |
Tyr157Phe-PDC1 | X2180-1A ura3∆::kanMX4 pdc1∆::hph pRS416::PDC1Tyr157Phe-myc7His |
Tyr344Phe-PDC1 | X2180-1A ura3∆::kanMX4 pdc1∆::hph pRS416::PDC1Tyr344Phe-myc7His |
Table 3
List of plasmids used in this study
Plasmids for S. cerevisiae | Marker | Type | Promoter | Protein to be produced |
pRS416 | URA3 | CEN | - | - |
pRS416-PDC1-myc7His | URA3 | CEN | PDC1 | Pdc1-myc7His |
pRS416-PDC1Tyr157Phe-myc7His | URA3 | CEN | PDC1 | Pdc1Tyr157Phe-myc7His |
pRS416-PDC1Tyr344Phe-myc7His | URA3 | CEN | PDC1 | Pdc1Tyr344Phe-myc7His |
Plasmids for E. coli | Marker | Description |
pET55-PDC1 | Ampr | To express Pdc1 fused with His-tag at its C-terminus |
pET55-PDC1Tyr38NT | Ampr | pET55-DEST to express PDC1 with amber codon at Tyr38 |
pET55-PDC1Tyr157NT | Ampr | pET55-DEST to express PDC1 with amber codon at Tyr157 |
pET55-PDC1Tyr344NT | Ampr | pET55-DEST to express PDC1 with amber codon at Tyr344 |
pDule-3-nitroTyrosine (5B) | Tetr | To express the Methanocaldococcus jannaschii NT-tRNA synthetase and the cognate amber suppressing tRNA for the production of NT-containing protein in E. coli |
To construct the plasmid expressing Pdc1-myc7His under the control of its original promoter, the DNA fragment from 1,000 bp upstream to downstream of PDC1 was amplified from the genomic DNA of the PDC1-myc7His strain using the primers listed in Table S1 and then introduced to pRS416 by the In-Fusion cloning system (Clontech) following the manufacturer’s protocol. The resultant plasmid pRS416-PDC1-myc7His was transformed to pdc1Δ ura3Δ cells, generating the strain expressing Pdc1-myc7His (the WT-PDC1 strain). The expression plasmid pET55-PDC1 used to produce Pdc1 fused with N-terminal strep-tag and C-terminal His-tag in E. coli was constructed as follows. The DNA fragment of PDC1 coding sequence was amplified from the genomic DNA of strain X2180-1A using the primers listed in Table S1 and then introduced to the entry plasmid pDONR221 by the BP reaction in Gateway technology (Invitrogen). The resultant plasmid pDONR221-PDC1 was subjected to the LR reaction with the plasmid pET55-DEST in Gateway technology, generating pET55-PDC1. Each reaction in Gateway technology was performed following the manufacturer’s protocol.
Yeast cells were cultured at 30 ˚C in YPD (1% yeast extract, 2% peptone, and 2% glucose) or SD (0.17% yeast nitrogen base without amino acids and ammonium sulfate, 0.5% ammonium sulfate, and 2% glucose, pH 4.0) medium, with 200 mg/L of G418, hygromycin B, or 100 mg/mL nourseothricin if necessary. For the SILAC experiment, 206.7 µM Arg and 205.2 µM Lys were supplied. E. coli cells were grown in LB medium (0.5% yeast extract, 1% tryptone, and 1% NaCl or M9 medium (0.8% glucose, 47.7 mM Na2HPO4, 22.0 mM KH2PO4, 0.05% NaCl, 0.1% NH4Cl, 2 mM MgSO4, 0.1 mM CaCl2, 0.4% casamino acid, and 0.5 mM thiamine), in the presence of 100 µg/mL ampicillin or 10 µg/mL tetracycline when necessary.
Construction of the plasmid expressing the PDC1 mutants. The site-directed mutagenesis to express each mutant of PDC1 was performed as previously described56, using the primers listed in Table S1 and pRS416-PDC1 to generate pRS416-PDC1Tyr157Phe-myc7His or pRS416-PDC1Tyr344Phe-myc7His, which expresses Pdc1-myc7His with Tyr157Phe or Tyr344Phe substitution, respectively. The plasmid pDONR221-PDC1 was used as a template with the primers listed in Table S1 to introduce the amber codon at the position corresponding to Tyr38, Tyr157, or Tyr344. The resultant pDONR221-PDC1 with mutation was subjected to the LR reaction in Gateway technology to generate the pET55-PDC1 plasmids with amber codon, pET55-PDC1Tyr38NT, pET55-PDC1Tyr157NT, and pET55-PDC1Tyr344NT. Successful mutagenesis was confirmed by DNA sequencing.
Acidified nitrite treatment of yeast. Yeast cells cultured in SD medium (pH 4.0) until the exponential growth phase were treated with 1 mM NaNO2 for 1 h at 30 ˚C. After treatment, cells were collected, frozen with liquid nitrogen, and stored at -80˚C for further analyses.
PDC and ADH activity. The PDC reaction was performed as previously described57. The assay mixture consisted of 40 mM imidazole-HCl buffer (pH 6.5), 0.2 mM thiamine pyrophosphate, 0.15 mM NADH, 88 U/mL alcohol dehydrogenase, 5 mM MgCl2, and the cell-free extract or purified Pdc1. The reaction was started by the addition of 50 mM pyruvate. The mixture for ADH reaction consisted of 100 mM phosphate buffer (pH 7.6), 8 mM acetaldehyde, and the cell-free extract. Both enzymatic activities were analyzed spectrophotometrically by monitoring a decrease of absorbance at 340 nm derived from NADH over time at 30 ˚C, using a spectrophotometer DU-800 (Beckman). One unit of the specific activity of PDC or ADH was defined as the amount of enzyme to oxidize 1 µmol of NADH per min.
Pull-down assay. After culture or treatment, the PDC1-myc7His cells were collected, washed, and resuspended in the extraction buffer (pH 7.4) containing 20 mM sodium phosphate, 0.5 M NaCl, 8 M urea, 20 mM imidazole, and Protease Inhibitor Cocktail (for Fungal and Yeast) (Wako Pure Chemical Industries), followed by cell disruption using Multi-beads shocker (Yasui Kikai) with glass beads. The supernatant after centrifugation was incubated with His Mag SepharoseTM Ni (Cytiva) equilibrated with the extraction buffer at 4˚C for 1 h with continuous rotation. After washing with the extraction buffer, Pdc1-myc7His was eluted with the elution buffer (pH 7.4) consisting of 20 mM sodium phosphate buffer, 0.5 M NaCl, 8 M urea, and 500 mM imidazole. Eluates were subjected to SDS-polyacrylamide gel electrophoresis (SDS-PAGE), followed by immunoblotting.
Western blot analysis. Protein concentration was measured by Bio-Rad Protein Assay Dye (Bio-Rad). The unified concentrations of protein extracts were separated by SDS-PAGE under the non-reducing conditions using Laemmli’s sample buffer without 2-mercaptoethanol and then transferred onto PVDF membranes. After the treatment with appropriate primary and secondary antibodies, the immunoblot was visualized using Amersham ECL prime reagents (GE Healthcare) and ImageQuantTM LAS4000 (GE Healthcare). For the negative control of PTN detection, the PVDF membrane was incubated with 10 mM sodium dithionite for 20 min before the treatment with anti-NT antibody.
Expression and purification of WT and NT incorporated Pdc1. In order to express the Pdc1 variants incorporating NT site-specifically, plasmid pET55-PDC1Tyr38NT, pET55-PDC1Tyr157NT, or pET55-PDC1Tyr344NT, which expresses Tyr38NT-, Tyr157NT-, or Tyr344NT-Pdc1, respectively, constructed as described above was used. E. coli BL21 (DE3) strain harboring each of these plasmids and the plasmid pDule-3-nitroTyrosine (5B) (Addgene)58 were cultured in M9CA medium at 37˚C. When OD600 reached 0.6, 0.1 mM isopropyl-β-D-thiogalactopyranoside and 1 mM NT were added and E. coli cells were further cultured for 16 h at 16ºC. After harvesting cells by centrifugation, the C-terminally His-tagged Pdc1 was purified by Ni SepharoseTM 6 Fast Flow (Cytiva) following the manufacturer’s protocol.
Identification of proteins with the PTN modification by LC-MS/MS. Proteomic analysis with SILAC method was performed to identify and quantify the NT-containing peptides. The arg1∆lys1∆ strain was cultured in SD medium at pH 4.0 containing Arg and Lys or Arg (guanido-13C) and Lys (4,4,5,5-D4) for the control or nitrite treatment condition, respectively. Cells cultured until the exponential phase were treated with 1 mM NaNO2 for 1 h and harvested. The same amount of extracted protein from each sample was mixed and subjected to SDS-PAGE under the non-reducing condition. Gels were treated with dithiothreitol, iodoacetamide, and trypsin, followed by LC-MS/MS analysis using Ion Trap-Orbitrap Mass Spectrometer LTQ-Orbitrap XL (Thermo Fisher Scientific). A database search was performed using Proteome Discoverer 1.4 (Thermo Fisher Scientific) with SequestHT node against the Saccharomyces cerevisiae database (NCBI). Searches were done with tryptic specificity allowing maximum 4 missed cleavage sites and a precursor mass tolerance of 10 ppm and fragment mass tolerance of 0.8 Da. Searched modifications were detected as followed: Acetyl / + 42.011 Da (Any N-Terminus), Oxidation / + 15.995 Da (M), Carbamidomethyl / + 57.021 Da (C), Nitro / + 44.985 Da (Y), Amino / + 15.011 Da (Y), Label:13C (1) / + 1.003 Da (R), Label:2H (4) / + 4.025 Da (K).
Quantification of ethanol content. Yeast cells in the exponential growth phase were incubated in SD medium with or without nitrite for 1 h. The ethanol concentration of supernatant was determined using Ethanol Colorimetric/Fluorometric Assay Kit (Biovision), following the manufacturer’s direction. Ethanol content in each sample was normalized by OD600 of the culture medium.
Quantification of pyruvate content. Yeast cells cultured until the logarithmic phase were treated with the acidified nitrite for 1 h, harvested, and suspended in the pyruvate assay buffer, provided in Pyruvate Assay Kit (Sigma-Aldrich). Cell-free lysate extracted using Multi-beads shocker was centrifuged and then subjected to ultrafiltration with Amicon Ultra (10 KDa) (Merck), to remove insoluble materials and proteins. Pyruvate concentration in the resultant solution was measured using Pyruvate Assay Kit. Pyruvate content in each sample was normalized by OD600 of the culture medium.